Related Experiment Video
Updated: Aug 1, 2025

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Forthcoming Developments in Models to Study the Hepatitis B Virus Replication Cycle, Pathogenesis, and
Sajad Ahmad Bhat1, Ishfaq Ahmad Ahanger1,2, Syed Naqui Kazim1
1Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.
Investigating chronic hepatitis B requires effective models. Human chimeric mice and in vitro systems offer promising avenues for studying hepatitis B virus (HBV) pathogenesis and developing new therapies.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Chronic hepatitis B can lead to liver cirrhosis and hepatocellular carcinoma.
- The pathogenesis and molecular mechanisms of hepatitis B virus (HBV) are not fully understood.
- Studying HBV is challenging due to its narrow species tropism, primarily infecting humans and higher primates.
Purpose of the Study:
- To review and discuss various models used for studying hepatitis B.
- To highlight the role of animal models, particularly human chimeric mice, in HBV research.
- To emphasize the need for developing in vitro cell culture systems for studying HBV replication and mechanisms.
Main Methods:
- Review of existing literature on animal models for hepatitis B research.
- Discussion of the development and utility of human chimeric mice.
- Exploration of in vitro cell culture systems for HBV studies.
Main Results:
- Animal models, including human chimeric mice, have advanced in vivo HBV research and therapeutic evaluation.
- Limitations of animal models include handling difficulties, accessibility issues, and high costs.
- In vitro cell culture systems are essential for detailed investigation of the HBV replication cycle and molecular mechanisms.
Conclusions:
- Human chimeric mice represent a significant advancement for in vivo HBV research.
- Developing robust in vitro cell culture systems is crucial for overcoming the limitations of animal models.
- A combination of in vivo and in vitro models is necessary for comprehensive understanding and treatment of chronic hepatitis B.
More Related Videos
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Viruses with RNA Genomes
Retrovirus Life Cycles
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

